Can across this review paper of LC/KD. It's the first I've read that seems to explore the metabolic and physiological effects of such a diet.
As a supporter of LCHF I will read this paper in full, but a quick read has rung warning bells in my head already. The way they have written their Introduction shows they may well have been fully behind LCHF when they started their study, and thus their findings may be just a tick box to confirm their beliefs, There is a danger this paper may contain bias toward keto diet, and may not be fully independent. They may be bending their science to fit the results, if you see what I mean,Can across this review paper of LC/KD. It's the first I've read that seems to explore the metabolic and physiological effects of such a diet. I'm rooting with moving from a moderate carb intake to low 50g down to 20g but as a T1D dear DKA this paper supports the theory that DKA is not result of ketogenic diet. Thoughts and experiences very welcome.
http://www.jpgmonline.com/article.a...e=63;issue=4;spage=242;epage=251;aulast=Gupta
You may be right, but then again you could be wrong, The cause of the DKA with SGLT-2 is not currently understood, but there are warnings on the FDA website, and there was an advisory sent out by NICE that GP's should provide warnings when prescribing SGLT-2 meds. But from feed back on this forum, that advice is not always given,I expect the issue (if any) with SGLT-2 inhibitors will turn out to be the risk of dehydration and low salt on a LCHF diet, along with SGLT-2 inhibitors incorrectly being given to people who produce little or none of their own insulin. (They are only licensed for Type2.) The combination of SGLT-2 inhibitor and low carb needs more research, but I can’t think of anyone with a vested interest to fund it…. (I have not seen any salid evidance that there is an issue, just people saying there is, as other people have said there is.)
For large scale, long term studies on Type2 control with Low Carb we will have to weight until Virthealth publishes more of their data, it will be well audicted, as they are working with large US health insurnce compnaeis on a "payment by results" bases.
Some T2 may be producing oodles of insulin, but may not be able to use it due to IR. Or they may be overdosing on glucose lowering meds and not adjusting it to follow the diet. Infection may also come into play especially an inflamed pancreas or pancreatitis, As I said earlier, alcohol may be involved. There may be other medical reasons why DKA could occur, and it seems SGLT-2 meds amplify the risk at low glucose levelsThe big issue with DKA and SGLT-2 is that most doctors assumes that someone can't be in DKA unless their BG is very high - this is not the case when SGLT-2 are in use. (Anyone with true Type2 producing much of their own insulin, can't get DKA.) As as keytones are expected to be detectable on low carb, thats another way to rule out DKA that can't be used....
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?